ArticleEuropean physical journal plus2021
Recurrent neural network ensemble, a new instrument for the prediction of infectious diseases.
Article in European physical journal plus, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 11 citations in OpenAlex.
- Neural network ensemble model for prediction of erythrocyte sedimentation rate (ESR) using partial least squares regression.Scientific reports · 2022Article
- Prediction of Incidence Trend of Influenza-Like Illness in Wuhan Based on ARIMA Model.Computational and mathematical methods in medicine · 2022Article
- Development of an Early Alert System for an Additional Wave of COVID-19 Cases Using a Recurrent Neural Network with Long Short-Term Memory.International journal of environmental research and public health · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Infectious diseases afflict human beings since ancient times. We can classify the infectious disease in two principal types: the emerging diseases, that are caused by new pathogens, and the re-emerging diseases, due to a new spread of a known pathogen. Both types can then be subdivided in natural, accidental or intentional spreads. The risk associated to infectious diseases strongly increased in the last decades, especially because of the globalisation, which leads to a denser and more efficient link between nations, involving that a local infectious may easily spread worldwide, such as the SARS-CoV-2 in 2019-2020. The development of new methods to predict the spread of diseases is crucial. However, sometimes the variables are too many that classical algorithms fail in the prediction. Aim of this work is to investigate the use of an ensemble of recurrent neural networks for disease prediction, using real flu's data to train and develop an instrument with the capability to determine the future flues. Two different types of study have been conducted. The first study investigates the influence of the neural network architecture, and it has been performed using 12 seasons to train the model and 3 seasons to test it. The second test aims to investigate the number of seasons needed to have a good prediction for future ones. The results demonstrated that this approach could ensure very high performances also with simple architectures. The ensemble approach allows to have information about the uncertainty of the prediction, allowing also to take countermeasures as a function of that value. In the future, the use of this approach may be applied to many other types of disease.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.